文献
J-GLOBAL ID:202002257172306592
整理番号:20A1858001
リボシクリブ薬物-薬物相互作用: 薬剤標識をガイドするための臨床評価と生理学的薬物動態モデリング【JST・京大機械翻訳】
Ribociclib Drug-Drug Interactions: Clinical Evaluations and Physiologically-Based Pharmacokinetic Modeling to Guide Drug Labeling
著者 (11件):
Samant Tanay S.
(Novartis Institutes for BioMedical Research, East Hanover, New Jersey, USA)
,
Huth Felix
(Novartis Institutes for BioMedical Research, Basel, Switzerland)
,
Umehara Kenichi
(Roche, Basel, Switzerland)
,
Schiller Hilmar
(Novartis Institutes for BioMedical Research, Basel, Switzerland)
,
Dhuria Shyeilla V.
(Amgen, San Francisco, California, USA)
,
Elmeliegy Mohamed
(Pfizer Inc., San Diego, California, USA)
,
Miller Michelle
(Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA)
,
Chakraborty Abhijit
(Novartis Institutes for BioMedical Research, East Hanover, New Jersey, USA)
,
Heimbach Tycho
(Novartis Institutes for BioMedical Research, East Hanover, New Jersey, USA)
,
He Handan
(Novartis Institutes for BioMedical Research, East Hanover, New Jersey, USA)
,
Ji Yan
(Novartis Institutes for BioMedical Research, East Hanover, New Jersey, USA)
資料名:
Clinical Pharmacology & Therapeutics
(Clinical Pharmacology & Therapeutics)
巻:
108
号:
3
ページ:
575-585
発行年:
2020年
JST資料番号:
A0721B
ISSN:
0009-9236
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)